Department of Error Department of Error
Howlett P, Walder A, Lisk D, et al. Neurological and psychiatric manifestations of post Ebola syndrome in Sierra Leone. Lancet 2017; 389 (suppl): S48 —In this Abstract, S Sevalie should have been listed as an author. This correction has been made to the online version as of Feb 1, 2018.
The TWiVerati follow up on the Ebola virus outbreak, virulence of Ebola-Makona, and reveal how a parasitoid is revealed to hyperparasitoids, and binding of influenza virus to a calcium ion channel to mediate influenza virus entry. <span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: hidden; line-height: […]
Congo's health ministry says there has been another death of a confirmed case of Ebola, bringing the number of fatalities to 12
[Guardian] As the Super Eagles prepare to tread tackles with their counterpart from Democratic Republic of Congo tomorrow, the Nigeria Football Federation (NFF) says there is no cause for alarm over the reported outbreak of Ebola Viral Disease (EVD) in that country.
Ebola is far from new in Congo, but each appearance is still considered a crisis — one that needs to be quickly contained.
Henry J. Kaiser Family Foundation. 05/25/2018 This issue brief examines what has changed in the larger international Ebola response landscape since 2014, and the current status of the U.S. Government engagement, including comparing the U.S. response now to a similar point in the trajectory of the 2014 outbreak. It details how the Democratic Republic of the Congo has experience with Ebola outbreaks, the World Health Organization has addressed important shortcomings, and an effective Ebola vaccine is available and being used. (Text)
Ebola vaccinations begin in rural Congo on Monday, ministry says, as confirmed cases up to 35
It is what fear sounds like.
, as vaccinations continue
Publication date: Available online 26 May 2018 Source:The Lancet Author(s): J Daniel Kelly, Patrick Mukadi, Ranu S Dhillon
We present here the generation and characterization of cross-reactive antibodies to both SUDV and EBOV, which were produced in a cell-free system and protective against SUDV in mice. A non-human primate, cynomolgus macaque, was immunized with viral-replicon particles expressing the glycoprotein of SUDV-Boniface (8A). Two separate antibody fragment phage display libraries were constructed after four immunogen injections. Both libraries were screened first against the SUDV and a second library was cross-selected against EBOV-Kikwit. Sequencing of 288 selected clones from the two distinct libraries identified 58 clones with d...